Collegium Pharmaceutical, Inc.

COLL Nasdaq SEC CIK 1267565
Follow Collegium Pharmaceutical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $216.3M +3.3% vs same quarter last year
Net income $21.8M −30.9% vs same quarter last year
EPS, diluted $0.60 −28.6% vs same quarter last year
Operating cash flow $86.5M +10.3% vs same quarter last year
Revenue by quarter
$181.9M
$177.8M
$188M
$209.4M
$205.4M
$193.5M
$199.9M
$216.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$250M$0$250M$500M$750M$1BFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$780.6M$63M
FY24$631.4M$69M
FY23$566.8M$48M
FY22$463.9M−$25M
FY21$276.9M$72M
FY20$310M$26.8M
FY19$296.7M−$22.7M
FY18$280.4M−$39.1M
FY17$28.5M−$74.9M
FY16$1.7M−$94.2M
FY15-−$27.3M
FY14-−$17.9M
FY13-−$16.2M
FY12--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2559.3%23%8.1%
FY2459.8%26.9%10.9%
FY2357.5%29.5%8.5%
FY2245.2%7.2%−5.4%
FY2154.4%6.4%26%
FY2058%18.1%8.6%
FY1934.7%−8%−7.7%
FY1840.9%−7.4%−14%
FY1790.9%−264.9%−262.9%
FY1687.6%−5498.7%−5504.1%
FY15---
FY14---
FY13---
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$200M$0$200M$400MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$327.6M
FY24$203.3M
FY23$274.3M
FY22$122.6M
FY21$101.6M
FY20$88.4M
FY19$21.3M
FY18$163.9M
FY17−$68M
FY16−$75.5M
FY15−$21.9M
FY14−$18M
FY13−$16.7M
FY12-
Returned to shareholdersDividends paid and shares bought back
$0$20M$40M$60M$80MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$25.1M
FY24$60M
FY23$75M
FY22$14.1M
FY21$47.9M
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Collegium Pharmaceutical
  • Healthcare median
−6000%−4000%−2000%0%2000%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCollegium PharmaceuticalHealthcare median
FY258.1%−30.6%
FY2410.9%−47%
FY238.5%−58%
FY22−5.4%−80.4%
FY2126%−71.8%
FY208.6%−62.2%
FY19−7.7%−46.2%
FY18−14%−49.6%
FY17−262.9%−45.9%
FY16−5504.1%−36%
FY15-−37.8%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%